Regulatory incentives are powerful tools in the development of alternatives to antimicrobials
The CVMP reflection paper considers the existing measures available to support the development of alternatives to antimicrobials in the field of veterinary medicine and seeks to identify where and how these measures may be improved.
The consultation comes at a critical time when the new veterinary medicines regulations (Regulation (EU) 2019/6) are being implemented and the EMA is consulting on and refining its Regulatory Science Strategy to 2025. It is crucial for the industry to engage with this consultation and to contribute to the ongoing debate, as regulatory incentives are essential tools to stimulate the research and development of medicines particularly in areas of unmet need.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.